ArticleThe journal of headache and pain2019
Burden of migraine in Finland: health care resource use, sick-leaves and comorbidities in occupational health care.
Article in The journal of headache and pain, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed.
- A National Cross-Sectional Survey on Real-World Experiences of Calcitonin Gene-Related Peptide (CGRP) Monoclonal Antibody Use in Adults with Migraine in Finland.Pain and therapy · 2025Article
- Short-term sick leave due to epilepsy in the Swedish Prospective Regional Epilepsy Database and Biobank for Individualized Clinical Treatment (PREDICT).Epilepsia open · 2025Article
- Preliminary External Validation Results of the Artificial Intelligence-Based Headache Diagnostic Model: A Multicenter Prospective Observational Study.Life (Basel, Switzerland) · 2024Article
- Neurological Diseases and Prevalence of Antineuronal Antibodies in Patients with Autoimmune Polyendocrine Syndrome Type 1 - A National Cohort Study.Journal of clinical immunology · 2024Article
- Treatment Patterns for and Characteristics of Headache in Children and Adolescents Aged 6-17 Years in Japan: A Retrospective Cross-Sectional and Longitudinal Analysis of Health Insurance Claims Data.Life (Basel, Switzerland) · 2024Article
- Healthcare resource utilization and associated costs among patients with migraine in Finland: A retrospective register-based study.PloS one · 2024Observational
- Health equity, care access and quality in headache - part 2.The journal of headache and pain · 2023Review
- Income dissatisfaction and migraine headache. Evidence from a nationwide population-based survey.Health psychology and behavioral medicine · 2023Article
- The Hidden Economic Consequences of Migraine to the UK Government: Burden-of-Disease Analysis Using a Fiscal Framework.Journal of health economics and outcomes research · 2023Article
- The disease burden of migraine patients receiving prophylactic treatments in Korea: a population-based claims database analysis.BMC health services research · 2022Article
- Erenumab Decreases Headache-Related Sick Leave Days and Health Care Visits: A Retrospective Real-World Study in Working Patients with Migraine.Neurology and therapy · 2022Article
- Hyperhidrosis Comorbidities and Treatments: A Register-based Study among 511 Subjects.Acta dermato-venereologica · 2022Article
- Association of temporomandibular disorder-related pain with severe headaches-a Bayesian view.Clinical oral investigations · 2022Article
- Prevalence of Migraine in General Spanish Population; Factors Related and Use of Health Resources.International journal of environmental research and public health · 2021Article
- Health Care Utilization and Costs in Patients With Migraine Who Have Failed Previous Preventive Treatments.Neurology. Clinical practice · 2021Article
- The migraine signature study: Methods and baseline results.Headache · 2021Article
- My Migraine Voice survey: disease impact on healthcare resource utilization, personal and working life in Finland.The journal of headache and pain · 2020Article
- Comparison of healthcare resource utilization and costs among patients with migraine with potentially adequate and insufficient triptan response.Cephalalgia : an international journal of headache · 2020Article
- Pain rates in general population for the period 1991-2015 and 10-years prediction: results from a multi-continent age-period-cohort analysis.The journal of headache and pain · 2020Article
- Is septal deviation associated with headache?: A nationwide 10-year follow-up cohort study.Medicine · 2020Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundThe highest prevalence of migraine is detected among people who are of working age. The aim of this study was to assess the burden of migraine in an occupational health care setting using real world data collected as a part of routine clinical practice.
methodsThis retrospective register study included migraineurs using occupational health care at the private health care provider Terveystalo. An age and gender matched control population was established for comparison. Electronic medical records were assessed for overall and migraine related health care visits, sick-leaves and comorbidities. Stratification to acute and prophylactic treatment groups along with prophylactic treatment lines was based on prescriptions.
resultsAmong the 369,383 individuals in the study cohort, 7.4% women and 2.1% men were identified having a diagnosis of migraine. Prophylactic medication was prescribed to 13% of migraine patients and exclusively acute medication to 37%. Although migraine related visits and sick-leave days were significantly lower than overall visits or sick-leave days, both increased by prophylactic treatment line. The number of visits rose from 13.8 to 26.2 and sick-leave days from 16.8 to 30.4 per patient-year, in those without prophylaxis vs. ≥3 prophylactic treatments. Moreover, migraine patients had 1.7-fold increase in visits and 1.8-fold increase in sick leave days on average per patient-year, when compared to the control population. Depression and anxiety were 1.8-fold more common among patients with migraine, and the frequency also increase by treatment line.
conclusionsMigraine burden increased by each failed treatment line and was associated with increased comorbidity. In addition, migraine patients had significantly higher extent of visits and sick-leave days as well as extent of comorbidities when compared to their age- and gender-matched counterparts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.